Systematic evaluation on direct economic burden of healthcare-associated infection due to multidrug-resistant organisms
10.3969/j.issn.1671-9638.2017.07.006
- VernacularTitle:多重耐药菌医院感染直接经济负担的系统评价
- Author:
Ling LING
;
Weixuan WU
;
Shumei SUN
;
Hao ZHOU
;
Fang YU
;
Qian XIANG
- Keywords:
healthcare-associated infection;
multidrug-resistant organism;
direct economic burden;
systematic evaluation
- From:
Chinese Journal of Infection Control
2017;16(7):616-621
- CountryChina
- Language:Chinese
-
Abstract:
Objective To understand the direct economic burden of healthcare-associated infection(HAI)due to multidrug-resistant organisms(MDROs).Methods Computer retrieval of CNKI,Wanfang,VIP,PubMed,Sci-enceDirect,and Cochrane databases on literatures about economic burden of MDRO HAI at home and abroad were performed,the retrieval time was from database establishment to December 2015,systematic evaluation of the liter-atures was obtained.Results According to the inclusion and exclusion criteria,as well as through Newcastle-Otta-wa Scale (NOS)for evaluating the literatures,19 literatures were included.In 12 studies about methicillin-resistant Staphylococcusaureus infection,the direct economic cost varied from $916.61 to $62908.00;in 4 studies about MDRO Acinetobacterbaumannii infection,the direct economic cost varied from$4644.00 to $98575.00.Direct economic cost due to extended-spectrumβ-lactamases-producing Enterobacteriaceae was $2824.14-$30093.00. Conclusion MDRO HAI will increase economic cost of both hospitals and patients,prevention and control measures should be taken .